GlassScriptPhysician profile
Derrick J Fluhme
NPI 1891775813
$16,514.11
in general payments reported to CMS, 2019-2025
24 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,259 · 2020: $8,260 · 2021: $1,501 · 2022: $657 · 2023: $443 · 2024: $169 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corentec America INC | $14,335.86 | 2019-2021 | |
| Vericel Corporation | $771.45 | 2021-2025 | Maci |
| Zimmer Biomet Holdings, INC. | $431.25 | 2021-2025 | Activbraid, Zeos, Comprehensive Shoulder System |
| Ferring Pharmaceuticals INC. | $182.40 | 2022-2024 | Euflexxa |
| Boston Scientific Corporation | $104.97 | 2021 | |
| Ethicon US, LLC | $76.07 | 2020-2023 | Vistaseal, Dermabond, Stratafix |
| Smith+Nephew, INC. | $73.57 | 2022 | |
| Pacira Therapeutics, INC. | $71.60 | 2021 | |
| Radius Health, INC. | $65.31 | 2021-2022 | |
| Bioventus LLC | $51.14 | 2020 | |
| Davol INC. | $50.20 | 2021 | |
| Electronic Waveform Lab, INC. | $47.91 | 2021-2024 | |
| Horizon Therapeutics Plc | $46.55 | 2019-2021 | |
| Stryker Corporation | $35.31 | 2021 | |
| Abbott Laboratories | $24.41 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $23.49 | 2019 | |
| Kci USA, INC. | $18.01 | 2021 | |
| Baudax Bio INC. | $17.34 | 2020 | |
| Depuy Synthes Sales INC. | $15.67 | 2022 | |
| Si-Bone, INC. | $15.46 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.43 | 2022 | |
| Pfizer INC. | $14.74 | 2020 | |
| Anika Therapeutics, INC. | $13.27 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Fluhme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.